These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1866164)

  • 1. [Experience with cytostatic therapy of stomach cancer].
    Kuklis B; Iliás L; Simig M; Sebesi J; Pattantyus J; Fiala E
    Orv Hetil; 1991 Aug; 132(31):1691-4. PubMed ID: 1866164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
    Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy].
    Wada T; Iwanaga T; Koyama H; Furukawa H; Akita N; Wada A; Yasutomi M
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):353-6. PubMed ID: 2449135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of liaison-clinical pathway for patients with gastric cancer undergoing adjuvant chemotherapy using S-1 after curative gastrectomy].
    Imamura H; Anami S; Watanabe M; Kishimoto T; Miyazaki Y; Kato H; Usui T; Masutani S; Tomotsu K; Furukawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1361-5. PubMed ID: 18701849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience in the treatment of 1108 patients with gastric carcinoma].
    Zhang XF
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):49-51. PubMed ID: 2364872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
    Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The future of loco-regional treatment for advanced gastric cancer].
    Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new chemotherapeutic regimen in the treatment of advanced gastric cancer.
    Kozaczka A; Machalski M
    Neoplasma; 1990; 37(1):77-84. PubMed ID: 2320183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of adjuvant chemotherapy for patients with early gastric cancer].
    Sasaki A; Furusawa M; Tomoda H; Seo Y; Ohno S; Matsukuma A; Morita M; Kakeji Y
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):37-45. PubMed ID: 8291914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stomach cancer: 10 years experiences with surgical treatment and possibilities for improving the prognosis].
    Spataro V; Genoni M; Maurer C; Müller W
    Helv Chir Acta; 1993 Mar; 59(4):589-95. PubMed ID: 8473176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary gastric lymphoma.
    Parvez T; Behani A; Ali A
    J Coll Physicians Surg Pak; 2007 Jan; 17(1):36-40. PubMed ID: 17204218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An unresectable gastric cancer radically resectable following UFT, ADM, MMC therapy].
    Watarai N; Kataoka M; Hayashi S; Tsuji H; Kasugai T; Taniwaki S; Kureyama Y; Mitsui T; Masaoka A; Kamejima N
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3467-71. PubMed ID: 2508569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
    Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
    Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
    Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin and S-1 combination therapy after reduction surgery for stage IV gastric cancer].
    Taniwaki S; Saruwatari A; Yoshida T; Mizoguchi A; Kitasato Y; Kitamura T; Hidaka A; Shiota K; Kuroda H; Tanaka M; Higashi T; Iwanaga Y; Ogata Y
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):279-82. PubMed ID: 19223745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.